Çà»çÀÏÁ¤ º¸±â
Çà»çºÐ·ù ±¹³»
Çà»çÁ¾·ù ±âŸ
Çà»çÄÚµå 2012_0316
Çà»ç¸í 2012 Ãá°è °£ÀÌ½Ä ¿¬±¸È¸ Áý´ãȸ ¹× Innovative ABCD Meeting
ÀϽà 2012-03-16
Àå¼Ò ¼­¿ï ±×·£µå ÀÎÅÍÄÜƼ³ÙÅ» È£ÅÚ
³»¿ë

ÀϽÃ: : 2012³â 3¿ù 16ÀÏ ±Ý¿äÀÏ

Àå¼Ò: ¼­¿ï ±×·£µå ÀÎÅÍÄÜƼ³ÙÅ» È£ÅÚ

 

1ºÎ: Ãá°è °£ÀÌ½Ä ¿¬±¸È¸ Áý´ãȸ (6:30 7:30)

ÁÖÁ¦: Transition from CTP to MELD ½ÉÃþ ÆгÎÅäÀÇ (ÁÂÀå: À̼®±¸)

6:30-6:45: MELDÀÇ °³¹ß ¹è°æ°ú Çѱ¹Çü MELD system ÃÊ¾È ¼Ò°³ (¿¬¼¼´ë ±è¸í¼ö) 15ºÐ

6:45-7:15 MELDÀüȯÀÇ ¸ðÀÇ ºÐ¼®

             - 1±Ç¿ª multi-center ÀÚ·á ºÐ¼® (¼­¿ï¾Æ»êº´¿ø Ȳ½Å)

- 1±Ç¿ª medium-volume center ÀÇ°ß (°í·Á´ë ±èµ¿½Ä)

             - 2/3±Ç¿ª center ÀÇ°ß (ÀüºÏ´ë À¯Èñö)

7:15-7:30 MELD ÃÊ¾È º¸¿Ï ¹× ¸ðÀÇ Àû¿ë¿¡ ´ëÇÑ ÆгΠÅäÀÇ

 

2ºÎ: Innovative ABCD meeting (Sponsored by Novartis)  (7:30 9:00 PM)

ÁÖÁ¦: Are we satisfied with current long-term outcome in Liver Transplantation? (ÁÂÀå: À̼®±¸, ±èµ¿±¸)

7:30-7:40 Welcome and Opening

7:40-8:20 The beneficial effect of CsA in liver transplantation and IS management for risk factor (focusing on DM, CV risk and HCV)

(Gary Levy, University of Toronto)

8:20-9:00 Prevention and treatment of HCC recurrence in the era of transplant benefit

(Umberto Cillo, University of Padua)

9:00-10:00 Management in real practice (Case review

À̱¤¿õ (¼­¿ï´ë), ¼Û±â¿ø (¼­¿ï¾Æ»êº´¿ø), ±ÇÁØÇõ (¼­¿ï»ï¼ºº´¿ø)


  2011 by The Korean Liver Transplantation Society. All rights reserved.
[06631] ¼­¿ï ¼­Ãʱ¸ ¼­ÃÊ´ë·Î62±æ 9-14 ¾ÆÀ̸®½º¼­ÃÊ 102µ¿ 201È£
TEL : 02-6677-0520   FAX : 02-6677-0536
°³ÀÎÁ¤º¸Ãë±Þ¹æħ